Nyxoah - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeNyxoah
Nyxoah logo

Nyxoah

0 followers

NYXH

Performance

About Nyxoah

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Its lead solution, Genio, uses hypoglossal nerve stimulation as an alternative to CPAP therapy to treat OSA, the world's most common sleep-disordered breathing condition. The company emphasizes relief from CPAP intolerance and aims to improve sleep health with implantable neuromodulation technologies, and it is headquartered in Mont-Saint-Guibert, Belgium, with activities described globally across the sleep medicine field.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

John Landry

Chief Financial Officer

Maggie McGowan

Chief HR Officer

Bruno Onkelinx

Chief Technical Officer

Scott Holstine

Chief Commercial Officer

Olivier Taelman

CEO

Key Facts

HQ Location

Mont-Saint-Guibert, Belgium

Founded

2009

Employees

51 - 200

Status

Public

Website

https://nyxoah.com